Aquatic Capital Management LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
Aquatic Capital Management LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$2,837
-5.4%
31,200
+31100.0%
0.18%
+17500.0%
Q2 2022$3,000
-87.0%
100
-85.7%
0.00%
-97.1%
Q1 2022$23,0007000.03%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$76,391,00014.09%
Opaleye Management Inc. 330,000$8,702,0001.85%
Highlander Partners, L.P. 27,600$728,0000.89%
Ikarian Capital, LLC 200,000$5,274,0000.79%
Integral Health Asset Management, LLC 103,000$2,716,0000.75%
KRS Capital Management, LLC 32,841$866,0000.74%
Ghost Tree Capital, LLC 55,000$1,450,0000.52%
MADDEN SECURITIES Corp 39,312$1,037,0000.49%
LBJ Family Wealth Advisors, Ltd. 30,359$801,0000.47%
Ikarian Capital, LLC 100,000$2,637,0000.39%
View complete list of REATA PHARMACEUTICALS INC shareholders